Patent ID: 7915283
Filing Date: 2011-03-29
Classification: A61P,C07D

Abstract:
1. A method for treating mammals infected with HIV, comprising administering to said mammal an antiviral effective amount of a compound of Formula I, including pharmaceutically acceptable salts thereof, wherein: Z is Q is selected from the group consisting of: —W— is R R R n is 0-6; R R -- represents a carbon-carbon bond; D is selected from the group consisting of hydrogen, (C A is selected from the group consisting of phenyl and heteroaryl; wherein said phenyl and heteroaryl are each independently optionally substituted with one to three same or different members selected from the group K; and heteroaryl is selected from the group consisting of pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, thienyl, benzothienyl, thiazolyl, isothiazolyl, oxazolyl, benzooxazolyl, isoxazolyl, imidazolyl, benzoimidazolyl, 1H-imidazo[4,5-b]pyridin-2-yl, 1H-imidazo[4,5-c]pyridin-2-yl, oxadiazolyl, thiadiazolyl, pyrazolyl, tetrazolyl, tetrazinyl, triazinyl and triazolyl; R B is selected from the group consisting of (C F is selected from the group consisting of (C G is selected from the group consisting of (C K is selected from the group consisting of (C R X is selected from the group consisting of NR R J is selected from the group consisting of (C R